Tenax Therapeutics, Inc. (TENX)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Oct 09, 16:00
1.89
+0.02
(+1.07%)
After-Hours: 20:00
Tenax Therapeutics Cash from Operations (Quarterly) : -14.15M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.15M |
| March 31, 2026 | -9.309M |
| December 31, 2025 | -13.42M |
| September 30, 2025 | -9.155M |
| June 30, 2025 | -6.263M |
| March 31, 2025 | -6.967M |
| December 31, 2024 | -3.527M |
| September 30, 2024 | -3.087M |
| June 30, 2024 | -3.031M |
| March 31, 2024 | -5.166M |
| December 31, 2023 | -1.174M |
| September 30, 2023 | -2.081M |
| June 30, 2023 | -0.923M |
| March 31, 2023 | -1.725M |
| December 31, 2022 | -2.313M |
| September 30, 2022 | -3.331M |
| June 30, 2022 | -3.431M |
| March 31, 2022 | -2.938M |
| December 31, 2021 | -2.768M |
| September 30, 2021 | -3.022M |
| June 30, 2021 | -1.845M |
| March 31, 2021 | -3.221M |
| December 31, 2020 | -1.987M |
| September 30, 2020 | -2.385M |
| June 30, 2020 | -2.229M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.671M |
| December 31, 2019 | -1.726M |
| September 30, 2019 | -1.782M |
| June 30, 2019 | -1.915M |
| March 31, 2019 | -2.133M |
| December 31, 2018 | -1.198M |
| September 30, 2018 | -1.556M |
| June 30, 2018 | -1.188M |
| March 31, 2018 | -1.558M |
| December 31, 2017 | -1.282M |
| September 30, 2017 | -1.226M |
| June 30, 2017 | -5.595M |
| March 31, 2017 | -4.037M |
| December 31, 2016 | -3.105M |
| September 30, 2016 | -4.281M |
| June 30, 2016 | |
| April 30, 2016 | |
| January 31, 2016 | |
| October 31, 2015 | |
| July 31, 2015 | -3.843M |
| April 30, 2015 | -1.627M |
| January 31, 2015 | -3.227M |
| October 31, 2014 | -2.912M |
| July 31, 2014 | -1.982M |
| April 30, 2014 | -2.980M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Exicure, Inc. | -0.887M |
| Century Therapeutics, Inc. | -19.83M |
| Absci Corp. | -27.56M |
| Celularity, Inc. | 1.447M |
| Cardio Diagnostics Holdings, Inc. | -1.342M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 13.37M |
| Free Cash Flow | -46.03M |
| Free Cash Flow Per Share (Quarterly) | -0.2782 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.15M |
| Free Cash Flow Yield | -55.70% |